Cargando…

Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study

BACKGROUND: Treatment of radiotherapy (RT) combined with immune checkpoint inhibitor (ICI) may remarkably improve the prognosis in patients with metastatic non-small cell lung cancer (NSCLC). However, the treatment time of RT, irradiated lesion and the optimum combined scheme, have not been fully de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yifan, Sun, Xiaorong, Hou, Yichen, Zhang, Mingzhu, Tan, Weiyue, Zhang, Yi, Wang, Jie, Zheng, Zhonghang, Li, Chaozhuo, Qi, Haoran, Hu, Mengyu, Xing, Ligang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323553/ https://www.ncbi.nlm.nih.gov/pubmed/37426122 http://dx.doi.org/10.21037/jtd-22-1685

Ejemplares similares

(18)F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer
por: Wang, Jie, et al.
Publicado: (2023)

Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer
por: Yang, Guanqun, et al.
Publicado: (2023)

Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review)
por: Wei, Chun, et al.
Publicado: (2023)

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis
por: Xiao, WeiWei, et al.
Publicado: (2022)

Immunoradiotherapy as an Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2020)

Comparison of Pneumonitis Rates and Severity in Patients With Lung Cancer Treated by Immunotherapy, Radiotherapy, and Immunoradiotherapy
por: Aiad, Mina, et al.
Publicado: (2022)

Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection
por: Hu, Yun, et al.
Publicado: (2023)

Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy
por: Qu, Jialin, et al.
Publicado: (2023)

Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy
por: Someya, Masanori, et al.
Publicado: (2022)

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma
por: Leidner, Rom, et al.
Publicado: (2021)

Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy
por: Landry, M.R., et al.
Publicado: (2020)

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
por: Hu, Yun, et al.
Publicado: (2022)

Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
por: Hu, Yun, et al.
Publicado: (2022)

Navigate Towards the Immunotherapy Era: Value of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Brain Metastases
por: Yang, Guanqun, et al.
Publicado: (2022)

Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer
por: Dong, Xinzhe, et al.
Publicado: (2016)

Prognostic Role Of Computed Tomography Textural Features In Early-Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy
por: Zhang, Ran, et al.
Publicado: (2019)

The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial
por: Wang, Jijin, et al.
Publicado: (2022)

Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis
por: Yang, Yifan, et al.
Publicado: (2021)

Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy
por: Zheng, Yawen, et al.
Publicado: (2021)

Clinical efficacy and safety of maintenance therapy for advanced non-small cell lung cancer: a retrospective real-world study
por: Xu, Xiangwei, et al.
Publicado: (2021)

Prognostic Value of (18)F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis
por: Liu, Jing, et al.
Publicado: (2016)

Functional status and spatial interaction of T cell subsets driven by specific tumor microenvironment correlate with recurrence of non-small cell lung cancer
por: Yang, Liying, et al.
Publicado: (2023)

Stage-Specific PET Radiomic Prediction Model for the Histological Subtype Classification of Non-Small-Cell Lung Cancer
por: Ji, Yanlei, et al.
Publicado: (2021)

Clinical Investigation of the Efficacy and Safety of Anlotinib with Immunotherapy in Advanced Non-Small Cell Lung Cancer as Third-Line Therapy: A Retrospective Study
por: Yang, Shengjie, et al.
Publicado: (2020)

The effectiveness and safety of acupuncture for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
por: Xu, Zhonghang, et al.
Publicado: (2022)

A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers
por: Li, Haoran, et al.
Publicado: (2022)

Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review
por: Li, Hong-Shuai, et al.
Publicado: (2022)

Safety and efficacy of thermal ablation for cervical metastatic lymph nodes in papillary thyroid carcinoma: A systematic review and meta-analysis
por: Tang, Wanqing, et al.
Publicado: (2022)

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study
por: Gu, Xiaodong, et al.
Publicado: (2022)

Distribution and Determinants of Unmet Need for Supportive Care Among Women with Breast Cancer in China
por: Wang, Shouhua, et al.
Publicado: (2018)

The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
por: Wang, Fen, et al.
Publicado: (2021)

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study
por: Zhao, Zhiting, et al.
Publicado: (2023)

Primary angiosarcoma of the small intestine metastatic to peritoneum with intestinal perforation: a case report and review of the literature
por: Liu, Zhicheng, et al.
Publicado: (2019)

The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study
por: Nie, Caiyun, et al.
Publicado: (2021)

Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer
por: Li, Jing, et al.
Publicado: (2022)

Perspective on treatment for unresectable locally advanced non-small cell lung cancer with oncogene-driven mutation: a narrative review
por: Jiang, Liyang, et al.
Publicado: (2020)

Efficacy and safety of surufatinib in the treatment of advanced solid tumors: a systematic evaluation and meta‑analysis
por: Cai, Tianying, et al.
Publicado: (2023)

The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study
por: Sun, Feifei, et al.
Publicado: (2020)

Efficacy and safety of chemotherapy for newly diagnosed advanced non-small cell lung cancer with venous thromboembolism
por: Zhang, Xueli, et al.
Publicado: (2015)

Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer
por: Jiang, Yifan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pr9kkb2hr2f51s4v0n9tip23g5